Article Details

FY2020 EPS Estimates for ADMA Biologics, Inc. (NASDAQ:ADMA) Increased by Analyst

Retrieved on: 2020-12-14 06:22:30

Tags for this article:

Click the tags to see associated articles and topics

FY2020 EPS Estimates for ADMA Biologics, Inc. (NASDAQ:ADMA) Increased by Analyst. View article details on hiswai:

Excerpt

The <b>biotechnology</b> company reported ($0.19) EPS for the quarter, meeting analysts' consensus estimates of ($0.19). ADMA Biologics had a negative ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo